Skip to main content
OpenTrials

Clinical trial condition

Non Small Cell Lung Cancer

Explore clinical trials studying Non Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

654 public trials 176 recruiting studies
Refine in advanced search Browse all conditions

Non Small Cell Lung Cancer trial results

Completed

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

NCT01061840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Florida Cancer Specialists West Palm Beach, Florida, United States
  • Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center Lebanon, New Hampshire, United States
  • Mary Crowley Cancer Research Centers Dallas, Texas, United States
  • Cancer Care Northwest Spokane, Washington, United States
View Trial Details
Completed

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

NCT02381314

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

NCT00982111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Nyack, New York, United States
  • ImClone Investigational Site Kogarah, New South Wales, Australia
  • ImClone Investigational Site Hobart, Tasmania, Australia
  • ImClone Investigational Site East Bentleigh, Victoria, Australia
View all 101 locations
View Trial Details
Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details

Related conditions